Your browser doesn't support javascript.
loading
A randomized phase II study of S-1 plus oral leucovorin versus S-1 monotherapy in patients with gemcitabine-refractory advanced pancreatic cancer.
Ueno, M; Okusaka, T; Omuro, Y; Isayama, H; Fukutomi, A; Ikeda, M; Mizuno, N; Fukuzawa, K; Furukawa, M; Iguchi, H; Sugimori, K; Furuse, J; Shimada, K; Ioka, T; Nakamori, S; Baba, H; Komatsu, Y; Takeuchi, M; Hyodo, I; Boku, N.
Affiliation
  • Ueno M; Division of Hepatobiliary and Pancreatic Medical Oncology, Kanagawa Cancer Center, Yokohama uenom@kcch.jp.
  • Okusaka T; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo.
  • Omuro Y; Department of Medical Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo.
  • Isayama H; Department of Gastroenterology, The University of Tokyo, Graduate School of Medicine, Tokyo.
  • Fukutomi A; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka.
  • Ikeda M; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Kashiwa.
  • Mizuno N; Department of Gastroenterology, Aichi Cancer Center Hospital, Nagoya.
  • Fukuzawa K; Department of Surgery, Oita Red Cross Hospital, Oita.
  • Furukawa M; Department of Gastroenterology, National Kyushu Cancer Center, Fukuoka.
  • Iguchi H; Department of Gastroenterology, National Hospital Organization Shikoku Cancer Center, Matsuyama.
  • Sugimori K; Gastroenterological Center, Yokohama City University Medical Center, Yokohama.
  • Furuse J; Department of Medical Oncology, Kyorin University School of Medicine, Tokyo.
  • Shimada K; Department of Medical Oncology, Saitama Medical University International Medical Center, Saitama.
  • Ioka T; Department of Hepatobiliary and Pancreatic Oncology, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka.
  • Nakamori S; Hepato-biliary-pancreatic Surgery, National Hospital Organization Osaka National Hospital, Osaka.
  • Baba H; Department of Gastroenterological Surgery, Kumamoto University, Kumamoto.
  • Komatsu Y; Department of Cancer Chemotherapy, Hokkaido University Hospital Cancer Center, Sapporo.
  • Takeuchi M; Department of Clinical Medicine (Biostatistics and Pharmaceutical Medicine), Kitasato University School of Pharmacy, Tokyo.
  • Hyodo I; Division of Gastroenterology, University of Tsukuba, Tsukuba.
  • Boku N; Department of Clinical Oncology, St Marianna University School of Medicine, Kawasaki, Japan.
Ann Oncol ; 27(3): 502-8, 2016 Mar.
Article in En | MEDLINE | ID: mdl-26681680
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oxonic Acid / Pancreatic Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Leucovorin / Tegafur / Antimetabolites, Antineoplastic Type of study: Clinical_trials Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2016 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oxonic Acid / Pancreatic Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Leucovorin / Tegafur / Antimetabolites, Antineoplastic Type of study: Clinical_trials Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2016 Document type: Article Country of publication: